Global Biobanking Market Size, Competition Landscape and Supply Chain Research Report 2025

Research Summary

Biobanking refers to the collection, storage, and management of biological samples and associated data for research purposes. A biobank is an organized repository that houses a large collection of biological materials, such as blood, tissue, cells, DNA, and other bodily fluids, along with relevant clinical and demographic information. Biobanks play a crucial role in advancing biomedical research, as they provide researchers with valuable resources for studying diseases, understanding genetic variations, developing new diagnostic tests, and discovering potential therapeutic targets. These samples can be used for a wide range of research areas, including genomics, proteomics, metabolomics, and personalized medicine. The establishment and operation of a biobank involve several important considerations. Ethical and legal aspects, such as informed consent, privacy protection, and data security, are of utmost importance to ensure the proper handling and use of the stored samples and associated information. Biobanks also follow strict quality control and standardization protocols to maintain the integrity and reliability of the collected samples. Furthermore, collaboration and partnerships between biobanks, researchers, and healthcare institutions are crucial for sharing samples and data, enabling larger-scale studies and maximizing the impact of research findings. Biobanks can be categorized into different types based on their focus and scope. Population-based biobanks collect samples from a specific population or community to study diseases and their causes within that population. Disease-oriented biobanks focus on collecting samples related to a specific disease or condition, such as cancer or cardiovascular diseases. Virtual biobanks leverage existing biobanks by aggregating data and samples from multiple sources to provide a comprehensive resource for researchers. Overall, biobanking plays a vital role in biomedical research, facilitating discoveries, and advancements in understanding human health and disease. It provides researchers with access to well-characterized biological materials, fostering collaborations, and ultimately improving healthcare outcomes.

According to WENKH research statistics, the global Biobanking market sales revenue reached  Million USD in 2024 and is expected to reach  Million USD by 2032, with a compound annual growth rate (CAGR) of  % from 2025 to 2032. Among them, the Asia-Pacific Biobanking market has experienced rapid changes in recent years, reaching  Million USD in 2024, accounting for approximately  % of the global market share. It is projected to reach  Million USD by 2032.

The global Biobanking market is highly competitive, with key market players including Thermo Fisher, Beckman Coulter, Panasonic, SOL Group, Promega, Merck, Greiner Bio One, Chart Industries, Brooks Life Science, Tecan Group, QIAGEN, BD, Lifeline Scientific, Hamilton, So-Low, TTP Labtech, Biolife Solutions, DNA Genotek, Custom Biogenic Systems, LVL Technologies, BioRep, Qingdao Haier Biomedical, OriginCell, Dashoo, Jiangsu Kangcheng Baiao Biotechnology, Takara Bio, Jiangsu Kangcheng Baiao Biotechnology, Wuxi NEST Biotechnology, etc. This report categorizes the competitive landscape of the global Biobanking market into three tiers based on annual revenue, with the top three market players holding approximately  % of the total market share.

This report provides an in-depth analysis of the global Biobanking market, including market size, price trends, market status and future development prospects. It particularly focuses on the market share, product characteristics, pricing, sales revenue, and gross profit margin of major players in the global Biobanking industry. Additionally, this report provides an in-depth analysis of the market status and future development trends of different product segments of Biobanking and their downstream application fields.

In terms of data, this report includes a comprehensive time-series dataset. The historical data spans from 2020 to 2024, providing a solid foundation for analyzing past market trends. The year 2025 is used as a base year to accurately assess the current market landscape. Forecast data covers the period from 2026 to 2032, utilizing scientific analysis methods and models to offer forward-looking predictions and insights into the market's future development. This provides valuable reference information for industry participants and stakeholders.

The report covers regions and countries including North America, Europe, China, Asia Pacific (excluding China), Latin America, the Middle East, and Africa. It particularly focuses on the sales revenue of Biobanking in these regions and countries, as well as the market share of key market players in each region. The report provides an in-depth analysis of the regional distribution and future development trends of the Biobanking market. By considering local policies, this report evaluates the market prospects of Biobanking in each region and country, aiming to help companies gain a comprehensive understanding of the industry characteristics and development potential in different regions, optimize regional business layout, and develop precise market strategies to achieve global development goals.

This report places a strong emphasis on data quality and reliability, utilizing diverse and extensive data sources to ensure the accuracy and validity of the information presented. Primary data collection involves multiple channels, including in-depth interviews with senior executives, industry experts, supply chain stakeholders, and end consumers. These interviews provide key insights into corporate strategic planning, industry policy interpretation, supply chain dynamics, and end-user experiences. Secondary data sources cover a wide range of authoritative statistics from government agencies, customs databases, industry associations, third-party paid databases, brokerage research reports, academic research findings, corporate annual reports, financial statements, real-time news updates, and relevant information from international organizations. These data sources serve as a solid foundation for verification and analysis.

Companies Covered

Thermo Fisher

Beckman Coulter

Panasonic

SOL Group

Promega

Merck

Greiner Bio One

Chart Industries

Brooks Life Science

Tecan Group

QIAGEN

BD

Lifeline Scientific

Hamilton

So-Low

TTP Labtech

Biolife Solutions

DNA Genotek

Custom Biogenic Systems

LVL Technologies

BioRep

Qingdao Haier Biomedical

OriginCell

Dashoo

Jiangsu Kangcheng Baiao Biotechnology

Takara Bio

Jiangsu Kangcheng Baiao Biotechnology

Wuxi NEST Biotechnology

Product Segment

Equipment

Consumable

Product Application

Virtual Biobanks

Tissue Biobanks

Population Biobanks

Chapter Scope

Chapter 1: Product Statistical Scope, Product Segmentation Types and Downstream Applications, Overall Market Size, Current Status and Development Prospects

Chapter 2: Global Biobanking Industry Chain Analysis

Chapter 3: Global Biobanking Industry Environment Analysis and Porter's Five Forces Analysis

Chapter 4: Analysis of the Competitive Landscape of Major Companies in the Global Biobanking Market (Market Share, Product Revenue Comparison, Tier Division, Corporate Expansion and M&A Trends)

Chapter 5: Analysis of Global Major Companies (Company Profiles, Product Features and Product Segment, Product Revenue, Product Average Price, Gross Profit Margin and Geographical Sales Share)

Chapter 6: Global Biobanking Product Segment and Downstream Application Size Analysis and Major Regional Market Size Analysis

Chapter 7: North America Biobanking Product Segment, Downstream Application, and Major Countries Market Size Analysis

Chapter 8: Europe Biobanking Product Segment, Downstream Application, and Major Countries Market Size Analysis

Chapter 9: China Biobanking Product Segment, Downstream Application, and Major Countries Market Size Analysis

Chapter 10: Asia Pacific (excluding China) Biobanking Product Segment, Downstream Application, and Major Countries Market Size Analysis

Chapter 11: Latin America Biobanking Product Segment, Downstream Application, and Major Countries Market Size Analysis

Chapter 12: Middle East and Africa Biobanking Product Segment, Downstream Application, and Major Countries Market Size Analysis

Chapter 13: Research Conclusion

Chapter 14: Methodology and Data Source

Purpose and Value of the Report

Market Trend Insights: Analyze industry trends, market dynamics, and future growth potential to help companies forecast changes and develop strategic plans.

Competitive Landscape Analysis: Understand key players' revenue segmentation, strategies, market share, and business models to guide competitive decisions.

Investment Decision Support: Provide feasibility analysis through market size, growth rate, demand trends, and potential risks for informed investment decisions.

Target Customer and Demand Analysis: Examine consumer behavior, purchasing preferences, and pain points to optimize products and improve market penetration.

Policy and Regulatory Insights: Interpret relevant industry policies to ensure compliance and mitigate regulatory risks.

Business Model Optimization: Offer data-driven suggestions for enhancing business models and improving profitability.